World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
31876
World Ranking
15437
National Ranking
7786

Overview

Kathy D. Miller is affiliated with Indiana University in the United States and has a research focus primarily within the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work extensively covers subfields including Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, as well as Molecular Biology.

Their main research topics include:

  • Breast Cancer Treatment Studies
  • Advanced Breast Cancer Therapies
  • Cancer Genomics and Diagnostics
  • HER2/EGFR in Cancer Research
  • Cancer Treatment and Pharmacology
  • Cancer Immunotherapy and Biomarkers
  • PARP inhibition in cancer therapy

Recent publications by Kathy D. Miller show a focus on breast cancer detection and treatment methodologies, with notable papers such as:

  • Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening (2020, JAMA)
  • Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer (2020, JAMA Oncology)
  • Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study (2021, The Lancet Oncology)
  • Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03) (2021, Journal of Clinical Oncology)
  • Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer (2020, Clinical Cancer Research)

Their most frequent coauthors include Bryan P. Schneider, Antonio C. Wolff, Tarah J. Ballinger, Erica L. Mayer, and Joseph A. Sparano.

Kathy D. Miller has contributed extensively to various scientific venues. The most common publication venues include:

  • Journal of Clinical Oncology
  • Cancer Research
  • Clinical Cancer Research
  • Annals of Oncology
  • JAMA Oncology

Best Publications

  • Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer

    Kathy Miller;Molin Wang;Julie Gralow;Maura Dickler

  • Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancer

    Kathy D. Miller;Linnea I. Chap;Frankie A. Holmes;Melody A. Cobleigh

  • Arterial Thromboembolic Events in Patients with Metastatic Carcinoma Treated with Chemotherapy and Bevacizumab

    Frank A. Scappaticci;Jamey R. Skillings;Scott N. Holden;Hans Peter Gerber

  • Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial of Paclitaxel Compared With Paclitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100

    Bryan P. Schneider;Molin Wang;Milan Radovich;George W. Sledge

  • NF-κ B Promotes Breast Cancer Cell Migration and Metastasis by Inducing the Expression of the Chemokine Receptor CXCR4

    Gregory Helbig;Kent W. Christopherson;Poornima Bhat-Nakshatri;Suresh Kumar

  • A Phase I/II Dose-Escalation Trial of Bevacizumab in Previously Treated Metastatic Breast Cancer

    Melody A Cobleigh;Virginia K Langmuir;George W Sledge;Kathy D Miller

  • Phase II Study of Sunitinib Malate, an Oral Multitargeted Tyrosine Kinase Inhibitor, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane

    Harold J. Burstein;Anthony D. Elias;Hope S. Rugo;Melody A. Cobleigh

  • Redefining the Target: Chemotherapeutics as Antiangiogenics

    Kathy D. Miller;Christopher J. Sweeney;George W. Sledge

  • Evaluation of Soy Phytoestrogens for the Treatment of Hot Flashes in Breast Cancer Survivors: A North Central Cancer Treatment Group Trial

    Susan K. Quella;Charles L. Loprinzi;Debra L. Barton;James A. Knost

  • Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Treatment With a Nonsteroidal Aromatase Inhibitor

    Denise A. Yardley;Roohi R. Ismail-Khan;Bohuslav Melichar;Mikhail Lichinitser

  • The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors.

    Christopher J. Sweeney;Kathy D. Miller;Sean E. Sissons;Shinichi Nozaki

  • A Phase II Study of Trastuzumab Emtansine in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Who Were Previously Treated With Trastuzumab, Lapatinib, an Anthracycline, a Taxane, and Capecitabine

    Ian E. Krop;Patricia LoRusso;Kathy D. Miller;Shanu Modi

  • Enzalutamide for the Treatment of Androgen Receptor–Expressing Triple-Negative Breast Cancer

    Tiffany T.A. Traina;Tiffany T.A. Traina;Kathy Miller;Denise Yardley;Janice Eakle

  • Angiogenesis of Breast Cancer

    Bryan P. Schneider;Kathy D. Miller

  • 64Cu-MM-302 positron emission tomography quantifies variability of enhanced permeability and retention of nanoparticles in relation to treatment response in patients with metastatic breast cancer

    Helen Lee;Anthony F. Shields;Barry A. Siegel;Kathy D. Miller

  • Impact of axillary lymph node dissection on the therapy of breast cancer patients.

    Paul P. Lin;David C. Allison;Jean Wainstock;Kathy D. Miller

  • Independent Review of E2100: A Phase III Trial of Bevacizumab Plus Paclitaxel Versus Paclitaxel in Women With Metastatic Breast Cancer

    Robert Gray;Suman Bhattacharya;Christopher Bowden;Kathy Miller

  • Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection among Women with Dense Breasts Undergoing Screening

    Christopher E. Comstock;Constantine Gatsonis;Gillian M. Newstead;Bradley S. Snyder

  • Breast cancer in vivo: contrast enhancement with thermoacoustic CT at 434 MHz-feasibility study.

    Robert A. Kruger;Kathy D. Miller;Handel E. Reynolds;William L. Kiser

  • Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells

    Brent W Sutherland;Jill Kucab;Joyce Wu;Cathy Lee

Frequent Co-Authors

George W. Sledge
George W. Sledge Stanford University
Joseph A. Sparano
Joseph A. Sparano Albert Einstein College of Medicine
Sunil Badve
Sunil Badve Emory University
Ian E. Krop
Ian E. Krop Harvard University
Antonio C. Wolff
Antonio C. Wolff Johns Hopkins University
Hope S. Rugo
Hope S. Rugo University of California, San Francisco
Patricia LoRusso
Patricia LoRusso Yale University
Ann H. Partridge
Ann H. Partridge Harvard University
Harikrishna Nakshatri
Harikrishna Nakshatri Indiana University
Harold J. Burstein
Harold J. Burstein Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in the medical field but want alternatives to a traditional MD, there are many online degrees and career pathways to consider. Possible options include administrative, clinical, and health sciences roles—all critical parts of the U.S. healthcare system.

For those drawn to leadership, healthcare administration degrees offer training in management, policy, and strategic planning. These programs can fast-track careers in hospital administration or health services management.

Registered nurses with an Associate’s Degree can progress to advanced practice roles through asn to nurse practitioner programs. These bridge programs are designed to be flexible and help nurses earn a master’s degree and gain specialized skills.

Students interested in nutrition and preventive care may pursue a bachelor's in nutrition online. Graduates can work as nutritionists, wellness coaches, or in public health.

Aspiring healthcare leaders looking for fully accredited graduate options can explore cahme accredited online mha programs. These programs ensure high educational standards and are valued by employers across the industry.

Best Scientists Citing Kathy D. Miller

Trending Scientists